Welcure Drugs & Pharmaceuticals

Small Cap 2.1k Result

₹3.89

As on 22 September, 2023 | 08:05 BSE: 524661 NSE: WELCUREISIN: INE331C01017

Welcure Drugs & Pharmaceuticals Performance

Day Range

Low
High

3.89

52 Week Range

Low
High

3.89

Open Price
Previous Close
Volume

Start SIP in Welcure Drugs & Pharmaceuticals

Start SIP

Welcure Drugs & Pharmaceuticals Share Price

Over 1 Month 2.64%
Over 3 Month -5.12%
Over 6 Month -0.51%
Over 1 Year -59.14%

Welcure Drugs & Pharmaceuticals Key Statistics

Welcure Drugs & Pharmaceuticals Investment Rating

Master Rating:
Welcure Drugs & Pharms. has an operating revenue of Rs. 0.17 Cr. on a trailing 12-month basis. An annual revenue growth of 118% is outstanding, Pre-tax margin of 0% needs improvement, ROE of 6% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 53 which is a POOR score indicating inconsistency in earnings, a RS Rating of 6 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 97 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Welcure Drugs & Pharmaceuticals Financials

Standalone Consolidated

Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Ratios
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Ratios

Indicator	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Oper Rev Qtr Cr	0	0	0	0	0	0
Operating Expenses Qtr Cr	0	0	0	0	0	0
Operating Profit Qtr Cr	0	0	0	0	0	0
Depreciation Qtr Cr	0	0	0	0	0	0
Interest Qtr Cr	0	0	0	0	0	0
Tax Qtr Cr	0	0	0	0	0	0
Net Profit Qtr Cr	0	0	0	0	0	0

Indicator	Mar 2023	Mar 2022
Total Revenue Annual Cr	0	0
Operating Expenses Annual Cr	0	0
Operating Profit Annual in Cr	0	0
Depreciation Cr	0	0
Interest Annual Cr	0	0
Tax Annual Cr	0	0
Net Profit Annual Cr	0	0

Indicator	Mar 2023	Mar 2022
Cash from Operating Activity Annual Cr		0
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr		0

Indicator	Mar 2023	Mar 2022
Total ShareHolders Funds Annual Cr	2	0
Fixed Assets Annual Cr	0	0
Total Non Current Assets Annual Cr	2	0
Total Current Assets Annual Cr	0	0
Total Assets Annual Cr	2	0

Indicator	Mar 2023	Mar 2022
Book Value Per Share Annual Rs	1	0
ROE Annual %	7	25
ROCE Annual %	7	25
Total Debt to Total Equity Annual	-	-
EBDIT Annual Margin %	0	22

Indicator	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr

Indicator	Mar 2023	Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr

Indicator	Mar 2023	Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr

Indicator	Mar 2023	Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr

Indicator	Mar 2023	Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual	-	-
EBDIT Annual Margin %

Welcure Drugs & Pharmaceuticals Technicals

EMA & SMA

Current Price

₹3.89

0 (0%)

Bullish Moving Average
___
11

Bearish Moving Average
___
5

EMA SMA

20 Day
₹3.83

50 Day
₹3.85

100 Day
₹4

200 Day
₹4.52

20 Day
₹3.83

50 Day
₹3.82

100 Day
₹3.9

200 Day
₹4.31

Welcure Drugs & Pharmaceuticals Resistance and Support

PIVOT

₹3.89

Resistance
First Resistance	₹3.89
Second Resistance	₹3.89
Third Resistance	₹3.89

RSI	54.32
MFI	38.21
MACD	0.01

Support
First Resistance	₹3.89
Second Resistance	₹3.89
Third Resistance	₹3.89

Welcure Drugs & Pharmaceuticals Delivery and Volume

Period	NSE + BSE Volume Avg	NSE + BSE Delivery Volume Avg	NSE + BSE Delivery Volume %
Day	14,314	1,417,372	99.02
Week	17,157	1,692,220	98.63
1 Month	36,207	3,094,983	85.48
6 Month	34,196	2,750,074	80.42

Welcure Drugs & Pharmaceuticals Result Highlights

Welcure Drugs & Pharmaceuticals Synopsis

BSE-Medical-Biomed/Biotech

Welcure Drugs & is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 13.44 Cr. for the Year ended 31/03/2023. Welcure Drugs & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 06/08/1996 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L24232DL1996PLC227773 and registration number is 227773.

Market Cap	5
Sales
Shares in Float	1.35
No of funds	1
Yield

Book Value	3.44
U/D Vol ratio	0.9
LTDebt / Equity
Alpha	-0.34
Beta	0.43

Welcure Drugs & Pharmaceuticals

Owner Name	Jun-23	Mar-23	Dec-22	Sep-22
Promoters
Financial Institutions/ Banks		0.01%	0.01%	0.01%
Individual Investors	93.67%	93.65%	93.73%	88.34%
Others	6.33%	6.34%	6.26%	11.65%

Welcure Drugs & Pharmaceuticals Management

Name	Designation
Mr. Dharam Chand Jain	Non Executive Director
Mr. Murari Lal Bhateja	Independent Director
Mr. Gagan Juneja	Independent Director
Ms. Mitashi Bisaria	Non Executive Director
Mr. Mayank Bhandari	Ind. Non-Executive Director
Mr. Vishal Mehra	Chairman & Managing Director

Welcure Drugs & Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)

1,758(-3.5%)

1,590(-12.7%)

Other Analyst Rating

Welcure Drugs & Pharmaceuticals Corporate Action

Board

Date	Purpose	Remarks
2023-08-14	Quarterly Results
2023-07-11	Quarterly Results
2023-05-29	Audited Results
2023-02-14	Quarterly Results	(Revised)
2022-11-29	Preferential issue of shares